Retatrutide: The Biological Reset for Rebound Fat Loss

#Retatrutide #GLP1 #WeightLossScience #ObesityMedicine #GLP1Masterclass Is retatrutide the real deal, or just another overhyped GLP-1 headline? In this video, Dr. Mohammed Paika — board-certified in Internal Medicine and Obesity Medicine — breaks down exactly how retatrutide's triple-hormone mechanism (GLP-1 + GIP + glucagon) works, what the Phase 2 trial data actually shows, and where the online hype outruns the evidence. You'll learn why weight loss and fat loss aren't the same thing, why muscle loss is the most overlooked risk on any GLP-1 medication (and exactly how to prevent it), what's really happening in your brain on these drugs, and the honest side-effect and safety picture — including the boxed warning most videos skip. Retatrutide is still investigational and has not been FDA-approved. This video is for education only and is not medical advice — always talk to your own physician before starting or changing any treatment. Want the complete framework for using GLP-1 therapy correctly — protein targets, a 12-week body recomposition program, and real answers to the questions patients ask every day in clinic? Check out the GLP-1 Masterclass at https://drmohammedpaika.com Timestamps 0:00 – Cold Open: Is Retatrutide Actually Different? 1:01 – The Disclaimer 1:50 – Meet Retatrutide: The Triple Agonist 2:42 – Lever One: GLP-1 3:48 – Lever Two: GIP 4:49 – Lever Three: Glucagon 7:10 – Three Levers, One Machine 7:49 – Quick Recap 8:33 – Why Your Body Actually Stores Fat 10:36 – Why the Scale Lies to You 12:16 – The Brain Connection 13:57 – The Part Everyone Gets Wrong: Muscle 17:45 – What the Trials Actually Show 19:26 – Side Effects & Who Should Be Cautious 21:02 – Is the Hype Ahead of the Evidence? 22:21 – What I Tell My Own Patients to Do 24:02 – Closing: The GLP-1 Masterclass GLP-1 Weight Loss Masterclass - https://www.drmohammedpaika.com Dr. Paika Podcast - https://drmohammedpaika.transistor.fm/ Amazon Kindle - https://www.amazon.it/GLP-1-Mastercla... 👨‍⚕️ ABOUT DR. MOHAMMED K. PAIKA Board-Certified in Internal Medicine and Obesity Medicine Certified Personal Trainer & Nutrition Coach Helping people understand metabolism, hormones, and sustainable health through evidence-based medicine. 👍 Like 💬 Comment 📌 Share 🔔 Subscribe for more honest conversations about obesity, metabolism, hormones, and real-world health solutions References [NEJM — Retatrutide Phase 2 Trial](https://www.nejm.org/doi/full/10.1056...) [PubMed — Jastreboff et al. 2023](https://pubmed.ncbi.nlm.nih.gov/37366...) [Triple Agonism Therapies for Obesity, NIH](https://pmc.ncbi.nlm.nih.gov/articles...) [GLP-1 & Muscle Mass, Cell Reports Medicine](https://www.cell.com/cell-reports-med...) [Mounjaro FDA Label — Boxed Warning](https://www.accessdata.fda.gov/drugsa...) [ClinicalTrials.gov — Retatrutide](https://clinicaltrials.gov/search?ter...) Note: retatrutide doesn't have its own FDA label yet since it's unapproved ⚕️ MEDICAL & EDUCATIONAL DISCLAIMER This channel and its content are provided by Dr. Mohammed K. Paika, MD for general educational and informational purposes only. The information presented is not intended as medical advice and does not replace consultation with your personal physician or qualified healthcare professional. Viewing this content does not create a doctor-patient relationship between you and Dr. Paika. Health, nutrition, exercise, and medication topics discussed on this channel may not be appropriate for all individuals. Always consult your own healthcare provider before starting or changing any medication, diet, exercise program, or weight-loss plan, including GLP-1 therapies such as Wegovy, Ozempic, Zepbound, Mounjaro, or similar medications. Exercise and lifestyle changes carry inherent risks. By choosing to follow any information from this channel, you accept full responsibility for your health decisions and outcomes. Dr. Paika and affiliated entities disclaim any liability for injuries, adverse effects, or damages resulting from use or application of information presented in this content.